1: (ROOT (S (NP (NP (NP (NP (NN Risk) (NNS Factors)) (PP (IN For) (NP (NP (CD COVI-19)) (JJ Related) (NNP Death)))) (PP (VBN IdentifiedBased) (PP (IN on) (NP (NP (NNS patients)) (VP (VP (VBN admitted) (PP (IN to) (NP (DT the) (NN hospital)))) (CC and) (VP (VBN confirmed) (S (VP (TO to) (VP (VB be) (VP (VBN infected) (PP (IN with) (NP (CD COVI-19))))))))))))) (NP (NP (DT the) (JJ key) (NN risk) (NNS factors)) (PP (IN for) (NP (NN death))))) (VP (VBP are) (: :) (NP (NP (NP (NNS signs)) (PP (IN of) (NP (NN sepsis)))) (, ,) (NP (NML (NN blood) (NN clotting)) (NNS issues)) (, ,) (NP (NN diabetes)) (, ,) (NP (NN heart) (NN disease)) (, ,) (CC and) (NP (JJ advanced) (NN age))) (, ,) (PP (VBG according) (PP (IN to) (NP (NP (NP (DT a) (JJ new) (JJ retrospective) (NN study)) (PP (VBN published) (PP (IN in) (NP (DT The) (NNP Lancet))))) (VP (VBG evaluating) (NP (NP (NNS data) (NN record)) (PP (IN for) (NP (NP (CD 191) (NNS patients)) (WHPP (IN of) (WHNP (WDT which))) (S (S (NP (NP (CD 54))) (VP (VBD did) (RB not) (VP (VB survive)))) (CC and) (S (NP (DT all) (NNS patients)) (VP (VBD had) (VP (VBN been) (VP (VBN admitted) (PP (IN to) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD 2) (NNS hospitals)) (PP (IN in) (NP (NP (DT the) (NN epicenter)) (PP (IN of) (NP (NP (NNP Wuhan)) (, ,) (NP (NNP China))))))))))))))))))))))) (. .)))
2: (ROOT (S ('' `) (S (NP (JJ Multivariable) (NN regression)) (VP (VBD showed) (NP (NP (NP (VBG increasing) (NNS odds)) (PP (IN of) (NP (FW i) (HYPH -) (NN hospital) (NN death)))) (VP (VBN associated) (PP (IN with) (NP (NP (JJR older) (NN age)) (, ,) (NP (JJR higher) (NML (NML (NNP Sequential) (NNP Organ) (NNP Failure)) (NNP Assessment)) (NN score)) (, ,) (CC and) (NP (NP (NN -dimer)) (ADJP (JJR greater) (PP (IN than) (NP (CD 1) (NN Î¼/L))) (PP (IN on) (NP (NN admission))))))))))) (, ,) ('' ') (S (NP (NP (DT the) (NN study) (POS 's)) (NNS authors)) (VP (VBD wrote))) (: ;) (S (S (NP (NP (NN age) (NN range)) (PP (IN for) (NP (NNS survivors)))) (VP (VBD was) (NP (HYPH 4) (CD -) (CD 58)))) (: ;) (SBAR (IN that) (S (PP (IN for) (NP (DT no) (HYPH -) (NNS survivors))) (VP (VBD was) (NP (CD 6) (CD -) (CD 76)))))) (. .)))
3: (ROOT (S (NP (DT This) (NN study)) (ADVP (RB also)) (VP (VBD provided) (NP (NP (NP (JJ new) (NNS findings)) (PP (IN on) (NP (JJ viral) (NN shedding)))) (SBAR (WHNP (WDT which)) (S (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (JJ median) (NN duration)) (PP (IN of) (NP (JJ viral) (NN shedding)))) (VP (VBD was) (NP (CD 20) (NNS days)) (PP (IN in) (NP (NP (NNS survivors)) (VP (VBG ranging) (PP (IN from) (NP (CD -37) (NNS days))))))))) (CC and) (SBAR (IN that) (S (NP (DT the) (NN virus)) (VP (VBD was) (ADJP (JJ detectable)) (PP (IN up) (PP (IN until) (NP (NN death)))) (PP (IN in) (NP (DT the) (FW no) (HYPH -) (NNS survivors)))))))))))) (. .)))
4: (ROOT (S (S (NP (VBN Prolonged) (JJ viral) (NN shedding)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS patients)) (VP (MD may) (ADVP (RB still)) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB spread) (NP (CD COVI-19)))))))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD was) (VP (VBN noted) (SBAR (IN that) (S (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ viral) (NN shedding)))) (VP (VBZ is) (VP (VBN influenced) (PP (PP (IN by) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN infection))))) (CC and) (PP (IN of) (NP (NP (NP (NP (DT those)) (PP (IN in) (NP (DT the) (NN study)))) (NP (CD two) (NNS thirds))) (VP (VBD had) (NP (ADJP (JJ severe) (CC or) (JJ critical)) (NN illness))))))))) (, ,) (CC and) (S (NP (DT the) (VBN estimated) (NN duration)) (VP (VBD was) (VP (VBN limited) (PP (IN by) (NP (NP (NP (JJ low) (NN frequency)) (PP (IN of) (NP (NML (JJ respiratory) (NN specimen)) (NN collection)))) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (JJ measurable) (NML (JJ genetic) (NN material)) (NN detection)) (PP (IN in) (NP (NNS samples)))))))))))))))) (. .)))
5: (ROOT (SINV ('' `) (S (NP (NP (DT The) (JJ extended) (JJ viral) (NN shedding)) (VP (VBN noted) (PP (IN in) (NP (PRP$ our) (NN study))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (S (VP (VBG guiding) (NP (NP (NNS decisions)) (PP (IN around) (NP (NP (NP (NN isolation) (NNS precautions)) (CC and) (NP (JJ antiviral) (NN treatment))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ confirmed) (CD COVI-19) (NN infection)))))))))))))) (, ,) ('' ') (VP (VBD explained)) (NP (NP (NML (NML (NN c) (HYPH -) (NN lead)) (NN author) (NN professor)) (NNP Bin) (NNP Cao)) (PP (IN from) (NP (NP (DT the) (NML (NNP Chin) (HYPH -) (NNP Japan)) (NNP Friendship) (NNP Hospital)) (CC and) (NP (NP (NNP Capital) (NNP Medical) (NNP University)) (, ,) (NP (NNP China)))))) (. .)))
6: (ROOT (S (ADVP (RB However)) (, ,) (NP (PRP we)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (JJ clear) (IN that) (S (NP (JJ viral) (NN shedding) (NN time)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN confused) (PP (IN with) (NP (NP (JJ other) (NML (NN sel) (HYPH -) (NN isolation)) (NN guidance)) (PP (IN for) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VP (MD may) (VP (VB have) (VP (VBN been) (VP (VBN exposed) (PP (IN to) (NP (CD COVI-19))))))) (CC but) (VP (VBP do) (RB not) (VP (VB have) (NP (NNS symptoms))))))))))) (, ,) (SBAR (IN as) (S (NP (DT this) (NN guidance)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN incubation) (NN time)) (PP (IN of) (NP (DT the) (NN virus))))))))))))))))) (. .) ('' ')))
7: (ROOT (S ('' `) (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (NP (JJ negative) (NNS tests)) (PP (IN for) (NP (CD COVI-19)))) (VP (MD should) (VP (VB be) (VP (VBN required) (SBAR (IN before) (S (NP (NNS patients)) (VP (VBP are) (VP (VBN discharged) (PP (IN from) (NP (NN hospital))))))))))))) (. .)))
8: (ROOT (S (PP (IN In) (NP (JJ severe) (NN influenza))) (, ,) (NP (VBN delayed) (JJ viral) (NN treatment)) (VP (VBZ extends) (SBAR (WHADVP (WRB how) (RB long)) (S (NP (DT the) (NN virus)) (VP (VBZ is) (VP (VBN shed)))))) (, ,) (CC and) (S (ADVP (RB together)) (NP (DT these) (NNS factors)) (VP (VBP put) (NP (JJ infected) (NNS patients)) (PP (IN at) (NP (NP (NN risk)) (PP (IN of) (NP (VBG dying))))))) (. .)))
9: (ROOT (S (ADVP (RB Similarly)) (, ,) (NP (JJ effective) (JJ antiviral) (NN treatment)) (VP (MD may) (VP (VB improve) (NP (NP (NNS outcomes)) (PP (IN in) (NP (CD COVI-19)))) (, ,) (SBAR (IN although) (S (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB observe) (NP (NP (NN shortening)) (PP (IN of) (NP (JJ viral) (NN shedding) (NN duration))) (PP (IN after) (NP (JJ antiviral) (NN treatment)))) (PP (IN in) (NP (PRP$ our) (NN study))))))))) (. .) ('' ')))
10: (ROOT (S ('' `) (NP (NP (NP (JJR Older) (NN age)) (, ,) (VP (VBG showing) (NP (NP (NNS signs)) (PP (IN of) (NP (NN sepsis))) (PP (IN on) (NP (NN admission)))))) (, ,) (NP (NP (VBG underlying) (NNS diseases)) (PP (IN like) (NP (NP (JJ high) (NN blood) (NN pressure)) (CC and) (NP (NN diabetes))))) (, ,) (CC and) (NP (NP (DT the) (JJ prolonged) (NN use)) (PP (IN of) (NP (JJ noninvasive) (NN ventilation))))) (VP (VBD were) (NP (NP (JJ important) (NNS factors)) (PP (IN in) (NP (NP (DT the) (NNS deaths)) (PP (IN of) (NP (DT these) (NNS patients))))))) (. .)))
11: (ROOT (SINV (S (NP (NP (JJR Poorer) (NNS outcomes)) (PP (IN in) (NP (JJR older) (NNS people)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (IN to) (NP (NP (NP (DT the) (ADJP (NN ag) (HYPH -) (VBN related)) (NN weakening)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))) (CC and) (NP (NP (VBN increased) (NN inflammation)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB promote) (NP (NP (JJ viral) (NN replication)) (CC and) (NP (NP (ADJP (RBR more) (JJ prolonged)) (NNS responses)) (PP (IN to) (NP (NN inflammation))))) (, ,) (S (VP (VBG causing) (NP (NP (JJ lasting) (NN damage)) (PP (IN to) (NP (NP (DT the) (NN heart)) (, ,) (NP (NN brain)) (, ,) (CC and) (NP (JJ other) (NNS organs)))))))))))))))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NML (NN c) (HYPH -) (NN author)) (NNP D.) (NNP Zhibo) (NNP Liu)) (PP (IN from) (NP (NP (NNP Jinyintan) (NNP Hospital)) (, ,) (NP (NNP China))))) (. .)))
12: (ROOT (S (NP (NP (JJ Median) (NN duration)) (PP (IN of) (NP (NN fever)))) (VP (VBD was) (NP (CD 12) (NNS days)) (PP (IN in) (NP (NNS survivors))) (, ,) (SBAR (IN while) (S (S (NP (DT the) (NN cough)) (VP (MD can) (VP (VB remain) (PP (IN for) (NP (DT a) (JJ long) (NN time)))))) (SBAR (IN as) (S (NP (NP (CD 45) (NN %)) (PP (IN of) (NP (DT the) (NNS survivors)))) (ADVP (RB still)) (VP (VBD had) (NP (DT a) (NN cough)) (PP (IN at) (NP (NN discharge))))))))) (. .)))
13: (ROOT (S (S (NP (NN Dyspnoea)) (VP (VBD ceased) (PP (IN after) (NP (NP (CD 13) (NNS days)) (PP (IN in) (NP (NNS survivors))))))) (, ,) (CC but) (S (NP (NP (DT the) (NN shortness)) (PP (IN of) (NP (NN breath)))) (VP (VBD lasted) (PP (IN until) (NP (NN death))) (PP (IN in) (NP (DT no) (HYPH -) (NNS survivors))))) (. .)))
14: (ROOT (S (NP (NNS Findings)) (ADVP (RB also)) (VP (VBP describe) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NP (NN occurrence)) (PP (IN of) (NP (NP (JJ different) (NNS complications)) (PP (JJ such) (IN as) (NP (NP (NN sepsis)) (, ,) (NP (NML (JJ acute) (JJ respiratory) (NN distress)) (NN syndrome)) (, ,) (NP (JJ acute) (JJ cardiac) (NN injury)) (, ,) (NP (JJ acute) (NN kidney) (NN injury)) (, ,) (CC and) (NP (JJ secondary) (NN infection)))))))))) (. .)))
15: (ROOT (S (S (NP (DT This) (NN analysis)) (VP (VBD included) (NP (NP (NP (NNS patients)) (VP (VBN aged) (NP (CD 18) (SYM +)))) (SBAR (WHNP (WP who)) (S (VP (VP (VBD were) (VP (NN laboratory) (VBN confirmed) (S (VP (TO to) (VP (VB have) (VP (VBN been) (VP (VBN infected) (PP (IN with) (NP (HYPH COVI-19)))))))))) (CC and) (VP (VBD were) (VP (VP (VBN admitted) (PP (IN to) (NP (CC either) (NP (NNP Jinyintan) (NNP Hospital)) (CC and) (NP (NNP Wuhan) (NNP Pulmonary) (NNP Hospital)))) (PP (IN after) (NP (NP (NNP December) (CD 29) (, ,) (CD 2019)) (, ,)))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (VP (VP (VBN discharged)) (CC or) (VP (VBN died)) (PP (IN by) (NP (NNP January) (CD 31) (, ,) (CD 2020)))))))))))))))) (: ;) (S (NP (DT these) (CD 2) (NNS sites)) (VP (VBD were) (NP (NP (DT the) (VBN designated) (NNS hospitals)) (PP (IN for) (S (VP (VBG transferring) (NP (NNS patients)) (PP (PP (IN to) (PP (IN with) (NP (JJ severe) (HYPH COVI-19)))) (PP (IN in) (NP (NNP Wuhan)))) (PP (IN until) (NP (NNP February) (. 1))))))))) (. .)))
16: (ROOT (NP (CD 2020) (. .)))
17: (ROOT (S (PP (IN For) (NP (DT this) (NN study))) (NP (NP (JJ clinical) (NNS records)) (, ,) (NP (NN treatment) (NNS data)) (, ,) (NP (NN lab) (NNS results)) (CC and) (NP (JJ demographic) (NNS data))) (VP (VBD was) (VP (VBN compared) (PP (IN between) (NP (NP (NP (NNS survivors) (CC and) (NNS nonsurvivors)) (VP (VBG examining) (NP (NP (DT the) (JJ clinical) (NN source)) (PP (IN of) (NP (NNS symptoms)))))) (, ,) (NP (JJ viral) (NN shedding)) (, ,) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (NN lab) (NNS results))) (PP (IN during) (NP (NN hospitalization)))))) (S (VP (VBG using) (NP (NP (JJ mathematical) (NN modeling)) (S (VP (TO to) (VP (VB examine) (NP (NP (NN risk) (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (NN mortality))))))))))))) (. .)))
18: (ROOT (S (NP (NNS Findings)) (VP (VBD showed) (SBAR (IN that) (S (S (PP (IN on) (ADJP (JJ average))) (S (NP (NNS patients)) (VP (VBD were) (ADJP (JJ middle) (JJ aged)) (PP (IN with) (NP (NP (DT a) (JJ median) (NN age)) (PP (IN of) (NP (CD 56) (NN year)))))))) (: ;) (S (NP (CD 62) (NN %)) (VP (VBD were) (NP (NNS men)))) (, ,) (CC and) (S (NP (CD 48) (NN %)) (VP (VBD had) (NP (NP (JJ underlying) (JJ chronic) (NNS conditions)) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (DT the) (ADJP (RBS most) (JJ common))) (VP (VBD was) (NP (NP (NP (JJ high) (NN blood) (NN pressure)) (PP (IN at) (NP (CD 30) (NN %)))) (CC and) (NP (NP (NN diabetes)) (PP (IN at) (NP (CD 19) (NN %)))))))))))))) (. .)))
19: (ROOT (S (S (PP (PP (IN From) (NP (NN illness) (NN onset))) (PP (IN to) (NP (NN discharge)))) (NP (DT the) (JJ median) (NN duration)) (VP (VBD was) (NP (CD 22) (NNS days)))) (, ,) (S (NP (NP (DT the) (JJ average) (NN duration)) (PP (IN until) (NP (NN death)))) (VP (VBD was) (NP (CD 1.5) (NNS days)))) (. .)))
20: (ROOT (S (NP (NP (DT Those)) (SBAR (WHNP (WP who)) (S (VP (VBD did) (RB not) (VP (VB survive)))))) (VP (VP (VBD were) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (JJR older))))))) (, ,) (CC and) (VP (VB have) (NP (NP (NP (NP (DT a) (JJR higher) (NN score)) (PP (IN on) (NP (DT the) (NML (NNP Sequential) (NNP Organ) (NNP Failure)) (NNP Assessment)))) (VP (VBG indicating) (NP (NN sepsis)))) (, ,) (CC and) (NP (NP (NP (VBN elevated) (NN blood) (NNS levels)) (PP (IN of) (NP (DT the) (JJR -dimer) (NN protein))) (PP (IN on) (NP (NN hospital) (NN admission)))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (NN coagulation))))))))))) (. .)))
21: (ROOT (S (NP (NP (JJR Lower) (NN lymphocyte) (NML (JJ white) (NN blood) (NN cell)) (NN count)) (, ,) (NP (NP (VBN elevated) (NNS levels)) (PP (IN of) (NP (NP (NNP Interleukin) (CD 6)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (NN biomarker)) (PP (IN for) (NP (NP (NN inflammation)) (CC and) (NP (JJ chronic) (NN disease))))))))))) (, ,) (CC and) (NP (NP (VBN increased) (JJ high) (NN sensitivity)) (PP (IN to) (NP (NML (NN troponin) (NN I)) (NN concentration))))) (VP (VBD were) (ADJP (RBR more) (JJ common)) (PP (IN in) (NP (NP (DT those)) (PP (IN with) (NP (NP (JJ severe) (NNS cases)) (PP (IN of) (NP (HYPH COVI-19) (NN infection)))))))) (. .)))
22: (ROOT (S (S (NP (NP (NN Frequency)) (PP (IN of) (NP (NP (NNS complications)) (PP (JJ such) (IN as) (NP (JJ respiratory) (NN failure)))))) (VP (VBD was) (NP (NP (CD 98) (NN %)) (PP (IN for) (NP (NNS nonsurvivors)))) (CC and) (NP (NP (CD 36) (NN %)) (PP (IN for) (NP (NNS survivors)))))) (: ;) (S (S (NP (NN sepsis)) (VP (VBD was) (NP (NP (CD 100) (NN %)) (PP (IN for) (NP (JJ non) (NNS survivors)))))) (CC and) (NP (NP (CD 42) (NN %)) (PP (IN for) (NP (NNS survivors))))) (: ;) (CC and) (S (NP (DT the) (JJ secondary) (NNS infections)) (VP (VP (VBD were) (NP (NP (CD 50) (NN %)) (PP (IN for) (NP (NNS nonsurvivors))))) (CC and) (VP (NP (QP (RB only) (CD 1)) (NN %)) (PP (IN in) (NP (NNS survivors)))))) (. .)))
23: (ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN noted) (SBAR (IN that) (S (NP (EX there)) (VP (VP (VBD were) (NP (NP (JJ several) (NNS limitations)) (PP (IN to) (NP (DT the) (NN study))) (PP (VBG including) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD excluded) (NP (NNS patients)) (WHNP (WP who)) (S (VP (VBD were) (ADVP (RB still)) (PP (IN in) (NP (NNS hospitals))) (PP (IN as) (PP (IN of) (NP (NNP January) (CD 3,202)))))) (SBAR (IN as) (S (NP (PRP they)) (VP (VBD had) (NP (ADJP (RB relatively) (RBR more) (JJ severe)) (NN disease)) (PP (IN at) (NP (DT an) (JJR earlier) (NN stage)))))))))))) (, ,) (ADVP (RB thus)) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS deaths)) (VP (VBN found) (PP (IN by) (NP (DT the) (NN study))))))) (VP (VP (VBZ does) (RB not) (VP (VB include) (NP (NP (DT any)) (PP (IN of) (NP (DT those) (NNS patients)))))) (CC and) (VP (MD may) (RB not) (VP (VB reflect) (NP (NP (DT the) (JJ true) (NN mortality)) (PP (IN of) (NP (CD COVI-19))))))))))))) (. .)))
24: (ROOT (S (ADVP (RB Also)) (NP (PRP it)) (VP (VP (VBD was) (VP (VBN pointed) (PRT (RP out)) (SBAR (IN that) (S (S (NP (QP (RB not) (DT all)) (NN laboratory) (NN test)) (VP (VBD were) (VP (VBN done) (PP (IN on) (NP (DT all) (NNS patients)))))) (, ,) (IN so) (S (NP (NP (PRP$ their) (JJ exact) (NN role)) (PP (IN in) (S (VP (VBG predicting) (PP (IN in) (NP (NN hospital) (NNS deaths))))))) (VP (MD may) (VP (VB be) (VP (VBN underestimated))))))))) (: ;) (CC and) (S (NP (NP (NP (NP (NN lack)) (PP (IN of) (NP (JJ effective) (NNS antivirals)))) (, ,) (NP (NP (JJ inadequate) (NN adherence)) (PP (IN to) (NP (JJ standard) (JJ supportive) (NN therapy)))) (, ,) (CC and) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NNS corticosteroids))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN transfer)) (PP (PP (IN of) (NP (DT some) (NNS patients))) (ADVP (RB late) (PP (IN in) (NP (NN illness))))))) (VP (MD may) (VP (VB have) (VP (VBN contributed) (PP (IN to) (NP (NP (JJ poor) (NNS outcomes)) (PP (IN in) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS patients)))))))))))) (. .)))
